KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares Outstanding
Ratios

Biogen (BIIB) Other Gross PP&E Adjustments (2016 - 2026)

Biogen has reported Other Gross PP&E Adjustments over the past 18 years, most recently at -$651.3 million for Q1 2026.

  • For Q1 2026, Other Gross PP&E Adjustments rose 6.48% year-over-year to -$651.3 million; the TTM value through Mar 2026 reached -$651.3 million, up 6.48%, while the annual FY2025 figure was $1.3 billion, 60.48% down from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 was -$651.3 million at Biogen, down from $1.3 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $3.2 billion in Q4 2024 and troughed at -$1.3 billion in Q1 2023.
  • A 5-year average of $3.0 million and a median of -$505.4 million in 2024 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 6653.33% in 2023 and later soared 212.75% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $2.5 billion in 2022, then tumbled by 59.81% to $1.0 billion in 2023, then soared by 212.75% to $3.2 billion in 2024, then tumbled by 60.48% to $1.3 billion in 2025, then tumbled by 152.09% to -$651.3 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for BIIB at -$651.3 million in Q1 2026, $1.3 billion in Q4 2025, and -$460.5 million in Q3 2025.